{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:22:07Z","timestamp":1794572527913,"version":"4.9.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI17802; R01AI153116; T32AI074492"],"award-info":[{"award-number":["R21 AI17802; R01AI153116; T32AI074492"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI17802; R01AI153116; T32AI074492"],"award-info":[{"award-number":["R21 AI17802; R01AI153116; T32AI074492"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI17802; R01AI153116; T32AI074492"],"award-info":[{"award-number":["R21 AI17802; R01AI153116; T32AI074492"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["GOLDBE23G0; DIGGLE18I0; DIGGLE20G0"],"award-info":[{"award-number":["GOLDBE23G0; DIGGLE18I0; DIGGLE20G0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["GOLDBE23G0; DIGGLE18I0; DIGGLE20G0"],"award-info":[{"award-number":["GOLDBE23G0; DIGGLE18I0; DIGGLE20G0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Antimicrob Resist"],"DOI":"10.1038\/s44259-025-00088-1","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T19:20:30Z","timestamp":1740770430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["R-pyocins as targeted antimicrobials against Pseudomonas aeruginosa"],"prefix":"10.1038","volume":"3","author":[{"given":"Madeline","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Diggle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna B.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"88_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0021-9258(17)41580-8","volume":"159","author":"EE Hays","year":"1945","unstructured":"Hays, E. E. et al. Antibiotic substances produced by Pseudomonas aeruginosa. Biol. Chem. 159, 725\u2013750 (1945).","journal-title":"Biol. Chem."},{"key":"88_CR2","first-page":"149","volume":"86","author":"F Jacob","year":"1954","unstructured":"Jacob, F. Induced biosynthesis and mode of action of a pyocine, an antibiotic obtained from Ps. pyocyanea. Ann. Inst. Pasteur 86, 149\u2013160 (1954).","journal-title":"Ann. Inst. Pasteur"},{"key":"88_CR3","first-page":"43","volume":"17","author":"R Hugh","year":"1967","unstructured":"Hugh, R. & Lessel, E. F. Pseudomonas aeruginosa or Pseudomonas pyocyanea? Int. J. Syst. Evol. Microbiol. 17, 43\u201351 (1967).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"88_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1128\/br.31.4.230-314.1967","volume":"31","author":"DE Bradley","year":"1967","unstructured":"Bradley, D. E. Ultrastructure of bacteriophage and bacteriocins. Bacteriol. Rev. 31, 230\u2013314 (1967).","journal-title":"Bacteriol. Rev."},{"key":"88_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-virology-101416-041632","volume":"4","author":"D Scholl","year":"2017","unstructured":"Scholl, D. Phage tail\u2013like bacteriocins. Annu. Rev. Virol. 4, 453\u2013467 (2017).","journal-title":"Annu. Rev. Virol."},{"key":"88_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0300-9084(02)01422-0","volume":"84","author":"Y Michel-Briand","year":"2002","unstructured":"Michel-Briand, Y. & Baysse, C. The pyocins of Pseudomonas aeruginosa. Biochimie 84, 499\u2013510 (2002).","journal-title":"Biochimie"},{"key":"88_CR7","first-page":"115","volume":"6","author":"D Bradley","year":"1966","unstructured":"Bradley, D. The structure of pyocin particles released from Pseudomonas aeruginosa by mitomycin C. Int. Congr. Electron Microscopy 6, 115\u2013116 (1966).","journal-title":"Int. Congr. Electron Microscopy"},{"key":"88_CR8","doi-asserted-by":"publisher","first-page":"e01828","DOI":"10.1128\/mBio.01828-18","volume":"10","author":"O Oluyombo","year":"2019","unstructured":"Oluyombo, O., Penfold, C. N. & Diggle, S. P. Competition in biofilms between cystic fibrosis isolates of Pseudomonas aeruginosa is shaped by R-pyocins. mBio 10, e01828\u201301818 (2019).","journal-title":"mBio"},{"key":"88_CR9","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1093\/oxfordjournals.jbchem.a133372","volume":"89","author":"K Kuroda","year":"1981","unstructured":"Kuroda, K. & Kageyama, M. Comparative study of F-type pyocins of Pseudomonas aeruginosa. J. Biochem. 89, 1721\u20131736 (1981).","journal-title":"J. Biochem."},{"key":"88_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/mbo3.210","volume":"3","author":"MG Ghequire","year":"2014","unstructured":"Ghequire, M. G. et al. O serotype-independent susceptibility of Pseudomonas aeruginosa to lectin-like pyocins. Microbiologyopen 3, 875\u2013884 (2014).","journal-title":"Microbiologyopen"},{"key":"88_CR11","doi-asserted-by":"crossref","unstructured":"Ghequire, M. G. K., \u00d6zt\u00fcrk, B. & De Mot, R. Lectin-like bacteriocins. Front. Microbiol. 9, 2706 (2018).","DOI":"10.3389\/fmicb.2018.02706"},{"key":"88_CR12","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/oxfordjournals.jbchem.a134533","volume":"94","author":"K Kuroda","year":"1983","unstructured":"Kuroda, K. & Kagiyama, R. Biochemical relationship among three F-type pyocins, pyocin F1, F2, and F3, and phage KF1. J. Biochem. 94, 1429\u20131441 (1983).","journal-title":"J. Biochem."},{"key":"88_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1046\/j.1365-2958.2000.02135.x","volume":"38","author":"K Nakayama","year":"2000","unstructured":"Nakayama, K. et al. The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Mol. Microbiol. 38, 213\u2013231 (2000).","journal-title":"Mol. Microbiol."},{"key":"88_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/jb.00029-23","volume":"205","author":"S Saha","year":"2023","unstructured":"Saha, S. et al. F-type pyocins are diverse noncontractile phage tail-like weapons for killing Pseudomonas aeruginosa. J. Bacteriol. 205, e0002923 (2023).","journal-title":"J. Bacteriol."},{"key":"88_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27341-1","volume":"13","author":"L Blasco","year":"2023","unstructured":"Blasco, L. et al. Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents. Sci. Rep. 13, 117 (2023).","journal-title":"Sci. Rep."},{"key":"88_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s44259-024-00045-4","volume":"2","author":"AM Sithu Shein","year":"2024","unstructured":"Sithu Shein, A. M. et al. Phage therapy could be key to conquering persistent bacterial lung infections in children. NPJ Antimicrob. Resist. 2, 31 (2024).","journal-title":"NPJ Antimicrob. Resist."},{"key":"88_CR17","doi-asserted-by":"crossref","unstructured":"Liu, D. et al. The safety and toxicity of phage therapy: a review of animal and clinical studies. J. Viruses 13, 1268 (2021).","DOI":"10.3390\/v13071268"},{"key":"88_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/oxfordjournals.jbchem.a127840","volume":"55","author":"K Ikeda","year":"1964","unstructured":"Ikeda, K., Kageyama, M. & Egami, F. Studies of a pyocin II. Mode of production of the pyocin. J. Biochem. 55, 54\u201358 (1964).","journal-title":"J. Biochem."},{"key":"88_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/oxfordjournals.jbchem.a127839","volume":"55","author":"M Kageyama","year":"1964","unstructured":"Kageyama, M. Studies of a pyocin I. Physical and chemical properties. J. Biochem. 55, 49\u201353 (1964).","journal-title":"J. Biochem."},{"key":"88_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goac012","volume":"10","author":"T Borodovich","year":"2022","unstructured":"Borodovich, T., Shkoporov, A. N., Ross, R. P. & Hill, C. Phage-mediated horizontal gene transfer and its implications for the human gut microbiome. Gastroenterol. Rep.10, goac012 (2022).","journal-title":"Gastroenterol. Rep."},{"key":"88_CR21","doi-asserted-by":"crossref","unstructured":"Ishii, S.-I., Nishi, Y. & Egami, F. The fine structure of a pyocin. J. Mol. Biol. 13, 428\u2013431 (1965).","DOI":"10.1016\/S0022-2836(65)80107-3"},{"key":"88_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35203-7","volume":"13","author":"CF Arias","year":"2022","unstructured":"Arias, C. F., Acosta, F. J., Bertocchini, F., Herrero, M. A. & Fern\u00e1ndez-Arias, C. The coordination of anti-phage immunity mechanisms in bacterial cells. Nat. Commun. 13, 7412 (2022).","journal-title":"Nat. Commun."},{"key":"88_CR23","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1128\/AAC.01660-08","volume":"53","author":"D Scholl","year":"2009","unstructured":"Scholl, D. et al. An Engineered R-type pyocin is a highly specific and sensitive bactericidal agent for the food-borne pathogen Escherichia coli O157:H7. Antimicrob. Agents Chemother. 53, 3074\u20133080 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"88_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1139\/cjm-2021-0207","volume":"67","author":"A Alqahtani","year":"2021","unstructured":"Alqahtani, A. et al. Recombinant R2-pyocin cream is effective in treating Pseudomonas aeruginosa-infected wounds. Can. J. Microbiol. 67, 919\u2013932 (2021).","journal-title":"Can. J. Microbiol."},{"key":"88_CR25","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1128\/AEM.00141-08","volume":"74","author":"SR Williams","year":"2008","unstructured":"Williams, S. R., Gebhart, D., Martin, D. W. & Scholl, D. Retargeting R-type pyocins to generate novel bactericidal protein complexes. Appl. Environ. Microbiol. 74, 3868\u20133876 (2008).","journal-title":"Appl. Environ. Microbiol."},{"key":"88_CR26","first-page":"1119","volume":"87","author":"M Ohsumi","year":"1980","unstructured":"Ohsumi, M., Shinomiya, T. & Kageyama, M. Comparative study on R-type pyocins of Pseudomonas aeruginosa. J. Biochem. 87, 1119\u20131125 (1980).","journal-title":"J. Biochem."},{"key":"88_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1099\/00221287-80-1-17","volume":"80","author":"JRW Govan","year":"1974","unstructured":"Govan, J. R. W. Studies on the pyocins of Pseudomonas aeruginosa: production of contractile and flexuous pyocins in Pseudomonas aeruginosa. J. Gen. Microbiol. 80, 17\u201330 (1974).","journal-title":"J. Gen. Microbiol."},{"key":"88_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/v10080427","volume":"10","author":"SA Buth","year":"2018","unstructured":"Buth, S. A., Shneider, M. M., Scholl, D. & Leiman, P. G. Structure and analysis of R1 and R2 pyocin receptor-binding fibers. J. Viruses 10, 427 (2018).","journal-title":"J. Viruses"},{"key":"88_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nsmb.2995","volume":"22","author":"P Ge","year":"2015","unstructured":"Ge, P. et al. Atomic structures of a bactericidal contractile nanotube in its pre- and postcontraction states. Nat. Struct. Mol. Biol. 22, 377\u2013382 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"88_CR30","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41586-020-2186-z","volume":"580","author":"P Ge","year":"2020","unstructured":"Ge, P. et al. Action of a minimal contractile bactericidal nanomachine. Nature 580, 658\u2013662 (2020).","journal-title":"Nature"},{"key":"88_CR31","doi-asserted-by":"publisher","first-page":"e0211432","DOI":"10.1371\/journal.pone.0211432","volume":"14","author":"AJ Salazar","year":"2019","unstructured":"Salazar, A. J., Sherekar, M., Tsai, J. & Sacchettini, J. C. R pyocin tail fiber structure reveals a receptor-binding domain with a lectin fold. PLoS ONE 14, e0211432 (2019).","journal-title":"PLoS ONE"},{"key":"88_CR32","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1128\/JB.01459-09","volume":"192","author":"T K\u00f6hler","year":"2010","unstructured":"K\u00f6hler, T., Donner, V. & van Delden, C. Lipopolysaccharide as shield and receptor for R-pyocin-mediated killing in Pseudomonas aeruginosa. J. Bacteriol. 192, 1921\u20131928 (2010).","journal-title":"J. Bacteriol."},{"key":"88_CR33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/oxfordjournals.jbchem.a129929","volume":"72","author":"T Shinomiya","year":"1972","unstructured":"Shinomiya, T. Studies on biosynthesis and morphogenesis of R-type pyocins of Pseudomonas aeruginosa. 3. Subunits of pyocin R and their precipitability by anti-pyocin R serum. J. Biochem. 72, 499\u2013510 (1972).","journal-title":"J. Biochem."},{"key":"88_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1042\/BST20210799","volume":"50","author":"JM Hardy","year":"2022","unstructured":"Hardy, J. M., Dunstan, R. A., Lithgow, T. & Coulibaly, F. Tall tails: cryo-electron microscopy of phage tail DNA ejection conduits. Biochem. Soc. Trans. 50, 459\u2013422W (2022).","journal-title":"Biochem. Soc. Trans."},{"key":"88_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/BF00325898","volume":"189","author":"T Shinomiya","year":"1983","unstructured":"Shinomiya, T., Shiga, S. & Kageyama, M. Genetic determinant of pyocin R2 in Pseudomonas aeruginosa PAO. I. Localization of the pyocin R2 gene cluster between the trpCD and trpE genes. Mol. Gen. Genet. 189, 375\u2013381 (1983).","journal-title":"Mol. Gen. Genet."},{"key":"88_CR36","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1128\/jb.175.5.1257-1263.1993","volume":"175","author":"H Matsui","year":"1993","unstructured":"Matsui, H., Sano, Y., Ishihara, H. & Shinomiya, T. Regulation of pyocin genes in Pseudomonas aeruginosa by positive (prtN) and negative (prtR) regulatory genes. J. Bacteriol. 175, 1257\u20131263 (1993).","journal-title":"J. Bacteriol."},{"key":"88_CR37","doi-asserted-by":"publisher","first-page":"e01230","DOI":"10.1128\/AEM.01230-18","volume":"84","author":"RJ Dorosky","year":"2018","unstructured":"Dorosky, R. J., Pierson, L. S. & Pierson, E. A. Pseudomonas chlororaphis produces multiple R-tailocin particles that broaden the killing spectrum and contribute to persistence in rhizosphere communities. Appl. Environ. Microbiol. 84, e01230\u201301218 (2018).","journal-title":"Appl. Environ. Microbiol."},{"key":"88_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tim.2015.07.011","volume":"23","author":"MGK Ghequire","year":"2015","unstructured":"Ghequire, M. G. K. & De Mot, R. The tailocin tale: peeling off phage tails. Trends Microbiol. 23, 587\u2013590 (2015).","journal-title":"Trends Microbiol."},{"key":"88_CR39","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1093\/gbe\/evv184","volume":"7","author":"MGK Ghequire","year":"2015","unstructured":"Ghequire, M. G. K. et al. Different ancestries of R tailocins in rhizospheric Pseudomonas isolates. Genome Biol. Evol. 7, 2810\u20132828 (2015).","journal-title":"Genome Biol. Evol."},{"key":"88_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41396-018-0261-3","volume":"13","author":"DA Baltrus","year":"2019","unstructured":"Baltrus, D. A., Clark, M., Smith, C. & Hockett, K. L. Localized recombination drives diversification of killing spectra for phage-derived syringacins. ISME J. 13, 237\u2013249 (2019).","journal-title":"ISME J."},{"key":"88_CR41","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2323\/jgam.20.269","volume":"20","author":"M Kageyama","year":"1974","unstructured":"Kageyama, M. Genetic mapping of pyocin R1 factor in Pseudomonas aeruginosa. J. Gen. Appl. Microbiol. 20, 269\u2013275 (1974).","journal-title":"J. Gen. Appl. Microbiol."},{"key":"88_CR42","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1128\/JB.01458-08","volume":"191","author":"RD Waite","year":"2009","unstructured":"Waite, R. D. & Curtis, M. A. Pseudomonas aeruginosa PAO1 pyocin production affects population dynamics within mixed-culture biofilms. J. Bacteriol. 191, 1349\u20131354 (2009).","journal-title":"J. Bacteriol."},{"key":"88_CR43","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1128\/JB.01889-14","volume":"196","author":"J Penterman","year":"2014","unstructured":"Penterman, J., Singh, P. K. & Walker, G. C. Biological cost of pyocin production during the SOS response in Pseudomonas aeruginosa. J. Bacteriol. 196, 3351\u20133359 (2014).","journal-title":"J. Bacteriol."},{"key":"88_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jbiotec.2019.11.003","volume":"307","author":"M Fernandez","year":"2020","unstructured":"Fernandez, M. et al. Characterization of the bacteriocins and the PrtR regulator in a plant-associated Pseudomonas strain. J. Biotech. 307, 182\u2013192 (2020).","journal-title":"J. Biotech."},{"key":"88_CR45","doi-asserted-by":"publisher","first-page":"e00064","DOI":"10.1128\/JB.00064-20","volume":"202","author":"Y Long","year":"2020","unstructured":"Long, Y. et al. Fis Contributes to resistance of Pseudomonas aeruginosa to ciprofloxacin by regulating pyocin synthesis. J. Bacteriol. 202, e00064\u201300020 (2020).","journal-title":"J. Bacteriol."},{"key":"88_CR46","doi-asserted-by":"publisher","first-page":"e01167","DOI":"10.1128\/spectrum.01167-22","volume":"10","author":"AS Bronson","year":"2022","unstructured":"Bronson, A. S., Baggett, N. S. & Cabeen, M. T. DNA damage-inducible pyocin expression is independent of RecA in xerC deleted Pseudomonas aeruginosa. Microbiol. Spectr. 10, e01167\u201301122 (2022).","journal-title":"Microbiol. Spectr."},{"key":"88_CR47","doi-asserted-by":"publisher","first-page":"e02893","DOI":"10.1128\/mBio.02893-21","volume":"12","author":"NS Baggett","year":"2021","unstructured":"Baggett, N. S., Bronson, A. S. & Cabeen, M. T. SOS-independent pyocin production in P. aeruginosa is induced by XerC recombinase deficiency. mBio 12, e02893\u201302821 (2021).","journal-title":"mBio"},{"key":"88_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.celrep.2013.12.019","volume":"6","author":"J Penterman","year":"2014","unstructured":"Penterman, J. et al. Rapid evolution of culture-impaired bacteria during adaptation to biofilm growth. Cell Rep. 6, 293\u2013300 (2014).","journal-title":"Cell Rep."},{"key":"88_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11220","volume":"7","author":"L Turnbull","year":"2016","unstructured":"Turnbull, L. et al. Explosive cell lysis as a mechanism for the biogenesis of bacterial membrane vesicles and biofilms. Nat. Commun. 7, 11220 (2016).","journal-title":"Nat. Commun."},{"key":"88_CR50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s42003-020-01581-1","volume":"4","author":"J Vacheron","year":"2021","unstructured":"Vacheron, J., Heiman, C. M. & Keel, C. Live cell dynamics of production, explosive release and killing activity of phage tail-like weapons for Pseudomonas kin exclusion. Commun. Biol. 4, 87 (2021).","journal-title":"Commun. Biol."},{"key":"88_CR51","doi-asserted-by":"publisher","first-page":"E4919","DOI":"10.1073\/pnas.1501064112","volume":"112","author":"B Hu","year":"2015","unstructured":"Hu, B., Margolin, W., Molineux, I. J. & Liu, J. Structural remodeling of bacteriophage T4 and host membranes during infection initiation. Proc. Natl Acad. Sci. USA 112, E4919\u2013E4928 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"88_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/00221287-80-1-1","volume":"80","author":"JR Govan","year":"1974","unstructured":"Govan, J. R. Studies on the pyocins of Pseudomonas aeruginosa: morphology and mode of action of contractile pyocins. J. Gen. Microbiol. 80, 1\u201315 (1974).","journal-title":"J. Gen. Microbiol."},{"key":"88_CR53","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1038\/s41396-021-00921-1","volume":"15","author":"S Carim","year":"2021","unstructured":"Carim, S. et al. Systematic discovery of Pseudomonad genetic factors involved in sensitivity to tailocins. ISME J. 15, 2289\u20132305 (2021).","journal-title":"ISME J."},{"key":"88_CR54","doi-asserted-by":"crossref","unstructured":"Kandel, P. P., Baltrus, D. A. & Hockett, K. L. Pseudomonas can survive tailocin killing via persistence-like and heterogenous resistance mechanisms. J. Bacteriol. 202, e00142-20 (2020).","DOI":"10.1128\/JB.00142-20"},{"key":"88_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2323\/jgam.19.115","volume":"19","author":"K Ikeda","year":"1973","unstructured":"Ikeda, K. & Egami, F. Lipopolysaccharide of Pseudomonas aeruginosa with special reference to pyocin R receptor activity. J. Gen. Appl. Microbiol. 19, 115\u2013128 (1973).","journal-title":"J. Gen. Appl. Microbiol."},{"key":"88_CR56","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/mmi.12289","volume":"89","author":"D Koc\u00edncov\u00e1","year":"2013","unstructured":"Koc\u00edncov\u00e1, D. & Lam, J. S. A deletion in the wapB promoter in many serotypes of Pseudomonas aeruginosa accounts for the lack of a terminal glucose residue in the core oligosaccharide and resistance to killing by R3-pyocin. Mol. Microbiol. 89, 464\u2013478 (2013).","journal-title":"Mol. Microbiol."},{"key":"88_CR57","unstructured":"ClinicalTrials.gov. A phase 1b\/2, multi-centered, randomized, double-blind, placebo-controlled trial of the safety and microbiological activity of a single dose of bacteriophage therapy in cystic fibrosis subjects colonized with Pseudomonas aeruginosa. ID NCT05453578 (2022)."},{"key":"88_CR58","doi-asserted-by":"crossref","unstructured":"Schooley, R. T. et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 61, e00954-17 (2017).","DOI":"10.1128\/AAC.00954-17"},{"key":"88_CR59","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1128\/jb.157.2.632-636.1984","volume":"157","author":"Y Uratani","year":"1984","unstructured":"Uratani, Y. & Hoshino, T. Pyocin R1 inhibits active transport in Pseudomonas aeruginosa and depolarizes membrane potential. J. Bacteriol. 157, 632\u2013636 (1984).","journal-title":"J. Bacteriol."},{"key":"88_CR60","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/femsre\/fuw007","volume":"40","author":"RF Maldonado","year":"2016","unstructured":"Maldonado, R. F., S\u00e1-Correia, I. & Valvano, M. A. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol. Rev. 40, 480\u2013493 (2016).","journal-title":"FEMS Microbiol. Rev."},{"key":"88_CR61","doi-asserted-by":"crossref","unstructured":"Faure, E., Kwong, K. & Nguyen, D. Pseudomonas aeruginosa in chronic lung infections: how to adapt within the host? Front. Immunol. 9, 2416 (2018).","DOI":"10.3389\/fimmu.2018.02416"},{"key":"88_CR62","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1128\/JCM.41.5.2158-2160.2003","volume":"41","author":"K Faure","year":"2003","unstructured":"Faure, K. et al. O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa. J. Clin. Microbiol. 41, 2158\u20132160 (2003).","journal-title":"J. Clin. Microbiol."},{"key":"88_CR63","doi-asserted-by":"crossref","unstructured":"Diggle, S. P & Whiteley, M. Microbe profile: Pseudomonas aeruginosa: opportunistic pathogen and lab rat. Microbiology 166, 30\u201333 (2020).","DOI":"10.1099\/mic.0.000860"},{"key":"88_CR64","doi-asserted-by":"crossref","unstructured":"Aswathanarayan, J. B., Rao, P., Siddaiahswamy, H. M., Sowmya, G. S. & Rai, R. V. Advances in Microbiology, Infectious Diseases and Public Health, Vol. 17 (ed. Donelli, G.) 55\u201375 (Springer, 2023).","DOI":"10.1007\/5584_2022_738"},{"key":"88_CR65","doi-asserted-by":"publisher","first-page":"e1004518","DOI":"10.1371\/journal.pgen.1004518","volume":"10","author":"KH Turner","year":"2014","unstructured":"Turner, K. H., Everett, J., Trivedi, U., Rumbaugh, K. P. & Whiteley, M. Requirements for Pseudomonas aeruginosa acute burn and chronic surgical wound infection. PLoS Genet. 10, e1004518 (2014).","journal-title":"PLoS Genet."},{"key":"88_CR66","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1128\/JB.185.4.1316-1325.2003","volume":"185","author":"DH Spencer","year":"2003","unstructured":"Spencer, D. H. et al. Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J. Bacteriol. 185, 1316\u20131325 (2003).","journal-title":"J. Bacteriol."},{"key":"88_CR67","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/jac\/dkl097","volume":"57","author":"A Sandiumenge","year":"2006","unstructured":"Sandiumenge, A. et al. Impact of diversity of antibiotic use on the development of antimicrobial resistance. J. Antimicrob. Chemother. 57, 1197\u20131204 (2006).","journal-title":"J. Antimicrob. Chemother."},{"key":"88_CR68","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ijmm.2010.08.008","volume":"300","author":"M Hogardt","year":"2010","unstructured":"Hogardt, M. & Heesemann, J. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int. J. Med. Microbiol. 300, 557\u2013562 (2010).","journal-title":"Int. J. Med. Microbiol."},{"key":"88_CR69","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1164\/rccm.201009-1430OC","volume":"183","author":"E Mowat","year":"2011","unstructured":"Mowat, E. et al. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am. J. Respir. Crit. Care Med. 183, 1674\u20131679 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"88_CR70","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1128\/JB.01050-12","volume":"194","author":"JCS Chung","year":"2012","unstructured":"Chung, J. C. S. et al. Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients. J. Bacteriol. 194, 4857 (2012).","journal-title":"J. Bacteriol."},{"key":"88_CR71","doi-asserted-by":"publisher","first-page":"e60225","DOI":"10.1371\/journal.pone.0060225","volume":"8","author":"M Workentine","year":"2013","unstructured":"Workentine, M. et al. Phenotypic Heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS ONE 8, e60225 (2013).","journal-title":"PLoS ONE"},{"key":"88_CR72","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tim.2016.01.008","volume":"24","author":"C Winstanley","year":"2016","unstructured":"Winstanley, C., O\u2019Brien, S. & Brockhurst, M. A. Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol. 24, 327\u2013337 (2016).","journal-title":"Trends Microbiol."},{"key":"88_CR73","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fcimb.2020.00173","volume":"10","author":"N Acosta","year":"2020","unstructured":"Acosta, N. et al. Cystic fibrosis patients infected with epidemic Pseudomonas aeruginosa strains have unique microbial communities. Front. Cell. Infect. Microbiol. 10, 173 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"88_CR74","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/s41396-020-0652-0","volume":"14","author":"S Azimi","year":"2020","unstructured":"Azimi, S. et al. Allelic polymorphism shapes community function in evolving Pseudomonas aeruginosa populations. ISME J 14, 1929\u20131942 (2020).","journal-title":"ISME J"},{"key":"88_CR75","doi-asserted-by":"publisher","first-page":"e03109","DOI":"10.1128\/mbio.03109-23","volume":"15","author":"J Vanderwoude","year":"2024","unstructured":"Vanderwoude, J., Azimi, S., Read Timothy, D. & Diggle Stephen, P. The role of hypermutation and collateral sensitivity in antimicrobial resistance diversity of Pseudomonas aeruginosa populations in cystic fibrosis lung infection. mBio 15, e03109\u2013e03123 (2024).","journal-title":"mBio"},{"key":"88_CR76","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/pathogens3030680","volume":"3","author":"AM Sousa","year":"2014","unstructured":"Sousa, A. M. & Pereira, M. O. Pseudomonas aeruginosa diversification during infection development in cystic fibrosis lungs\u2014a review. J. Pathog. 3, 680\u2013703 (2014).","journal-title":"J. Pathog."},{"key":"88_CR77","doi-asserted-by":"publisher","first-page":"e01773","DOI":"10.1128\/spectrum.01773-23","volume":"11","author":"M Mei","year":"2023","unstructured":"Mei, M., Pheng, P., Kurzeja-Edwards, D. & Diggle, S. P. High prevalence of lipopolysaccharide mutants and R2-pyocin susceptible variants in Pseudomonas aeruginosa populations sourced from cystic fibrosis lung infections. Microbiol. Spectr. 11, e01773\u201301723 (2023).","journal-title":"Microbiol. Spectr."},{"key":"88_CR78","doi-asserted-by":"publisher","first-page":"e00458","DOI":"10.1128\/mBio.00458-21","volume":"12","author":"M Mei","year":"2021","unstructured":"Mei, M., Thomas, J. & Diggle, S. P. Heterogenous susceptibility to R-pyocins in populations of Pseudomonas aeruginosa sourced from cystic fibrosis lungs. mBio 12, e00458\u201300421 (2021).","journal-title":"mBio"},{"key":"88_CR79","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1093\/jac\/dky261","volume":"73","author":"M Redero","year":"2018","unstructured":"Redero, M. et al. Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients. J. Antimicrob. Chemother. 73, 2770\u20132776 (2018).","journal-title":"J. Antimicrob. Chemother."},{"key":"88_CR80","doi-asserted-by":"publisher","first-page":"180623","DOI":"10.1098\/rsos.180623","volume":"5","author":"JJ Bara","year":"2018","unstructured":"Bara, J. J., Matson, Z. & Remold, S. K. Life in the cystic fibrosis upper respiratory tract influences competitive ability of the opportunistic pathogen Pseudomonas aeruginosa. R. Soc. Open Sci. 5, 180623 (2018).","journal-title":"R. Soc. Open Sci."},{"key":"88_CR81","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa121","author":"M Redero","year":"2020","unstructured":"Redero, M., Aznar, J. & Prieto, A. I. Antibacterial efficacy of R-type pyocins against Pseudomonas aeruginosa on biofilms and in a murine model of acute lung infection. J. Antimicrob. Chemother. https:\/\/doi.org\/10.1093\/jac\/dkaa121 (2020).","journal-title":"J. Antimicrob. Chemother."},{"key":"88_CR82","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","volume":"21-22","author":"A Oliver","year":"2015","unstructured":"Oliver, A., Mulet, X., L\u00f3pez-Causap\u00e9, C. & Juan, C. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist. Updat. 21-22, 41\u201359 (2015).","journal-title":"Drug Resist. Updat."},{"key":"88_CR83","doi-asserted-by":"crossref","unstructured":"Rada, A. M. et al. Genetic diversity of multidrug-resistant Pseudomonas aeruginosa isolates carrying blaVIM\u20132 and blaKPC\u20132 genes that spread on different genetic environment in Colombia. Front. Microbiol. 12, 663020 (2021).","DOI":"10.3389\/fmicb.2021.663020"},{"key":"88_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106196","volume":"56","author":"E del Barrio-Tofi\u00f1o","year":"2020","unstructured":"del Barrio-Tofi\u00f1o, E., L\u00f3pez-Causap\u00e9, C. & Oliver, A. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired \u03b2-lactamases: 2020 update. Int. J. Antimicrob. Agents 56, 106196 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"88_CR85","doi-asserted-by":"publisher","first-page":"E5125","DOI":"10.1073\/pnas.1717525115","volume":"115","author":"DM Cornforth","year":"2018","unstructured":"Cornforth, D. M. et al. Pseudomonas aeruginosa transcriptome during human infection. Proc. Natl Acad. Sci. USA 115, E5125\u2013E5134 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"88_CR86","doi-asserted-by":"crossref","unstructured":"Cornforth, D. M., Diggle, F. L., Melvin, J. A., Bomberger, J. M. & Whiteley, M. Quantitative framework for model evaluation in microbiology research using Pseudomonas aeruginosa and cystic fibrosis infection as a test case. mBio 11, e03042-19 (2020).","DOI":"10.1128\/mBio.03042-19"},{"key":"88_CR87","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1021\/acs.jproteome.9b00122","volume":"18","author":"X Wu","year":"2019","unstructured":"Wu, X. et al. in vivo proteome of Pseudomonas aeruginosa in airways of cystic fibrosis patients. J. Proteome Res. 18, 2601\u20132612 (2019).","journal-title":"J. Proteome Res."},{"key":"88_CR88","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.1073\/pnas.1419677112","volume":"112","author":"KH Turner","year":"2015","unstructured":"Turner, K. H., Wessel, A. K., Palmer, G. C., Murray, J. L. & Whiteley, M. Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum. Proc. Natl Acad. Sci. USA 112, 4110\u20134115 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"88_CR89","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1128\/AAC.01479-07","volume":"52","author":"D Scholl","year":"2008","unstructured":"Scholl, D. & Martin, D. W. Antibacterial efficacy of R-type pyocins towards Pseudomonas aeruginosa in a murine peritonitis model. Antimicrob. Agents Chemother. 52, 1647\u20131652 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"88_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47192-w","volume":"15","author":"JD Berkson","year":"2024","unstructured":"Berkson, J. D. et al. Phage-specific immunity impairs efficacy of bacteriophage targeting vancomycin resistant Enterococcus in a murine model. Nat. Commun. 15, 2993 (2024).","journal-title":"Nat. Commun."},{"key":"88_CR91","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.3390\/antibiotics11101358","volume":"11","author":"M \u0141usiak-Szelachowska","year":"2022","unstructured":"\u0141usiak-Szelachowska, M. et al. Do anti-phage antibodies persist after phage therapy? A preliminary report. J. Antibiot. 11, 1358 (2022).","journal-title":"J. Antibiot."},{"key":"88_CR92","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.medj.2024.05.017","volume":"5","author":"M Bernab\u00e9u-Gimeno","year":"2024","unstructured":"Bernab\u00e9u-Gimeno, M. et al. Neutralizing antibodies after nebulized phage therapy in cystic fibrosis patients. Med 5, 1096\u20131111.e1096 (2024).","journal-title":"Med"},{"key":"88_CR93","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.tim.2023.04.008","volume":"31","author":"K Champagne-Jorgensen","year":"2023","unstructured":"Champagne-Jorgensen, K., Luong, T., Darby, T. & Roach, D. R. Immunogenicity of bacteriophages. Trends Microbiol. 31, 1058\u20131071 (2023).","journal-title":"Trends Microbiol."},{"key":"88_CR94","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","volume":"25","author":"RM Dedrick","year":"2019","unstructured":"Dedrick, R. M. et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat. Med. 25, 730\u2013733 (2019).","journal-title":"Nat. Med."},{"key":"88_CR95","doi-asserted-by":"publisher","first-page":"e60575","DOI":"10.1371\/journal.pone.0060575","volume":"8","author":"E Christiane","year":"2013","unstructured":"Christiane, E. et al. The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophages. PLoS ONE 8, e60575 (2013).","journal-title":"PLoS ONE"},{"key":"88_CR96","doi-asserted-by":"crossref","unstructured":"Forti, F. et al. Design of a broad-range bacteriophage cocktail that reduces Pseudomonas aeruginosa biofilms and treats acute infections in two animal models. Antimicrob. Agents Chemother. 62, e02573-17 (2018).","DOI":"10.1128\/AAC.02573-17"},{"key":"88_CR97","doi-asserted-by":"crossref","unstructured":"Shafigh Kheljan, F. et al. Design of phage-cocktail-containing hydrogel for the treatment of Pseudomonas aeruginosa-infected wounds. J. Viruses 15, 803 (2023).","DOI":"10.3390\/v15030803"},{"key":"88_CR98","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41551-018-0263-5","volume":"2","author":"R Agarwal","year":"2018","unstructured":"Agarwal, R. et al. Inhaled bacteriophage-loaded polymeric microparticles ameliorate acute lung infections. Nat. Biomed. Eng. 2, 841\u2013849 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"88_CR99","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1128\/AAC.10.2.354","volume":"10","author":"SA Morse","year":"1976","unstructured":"Morse, S. A., Vaughan, P., Johnson, D. & Iglewski, B. H. Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 10, 354\u2013362 (1976).","journal-title":"Antimicrob. Agents Chemother."},{"key":"88_CR100","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1099\/00222615-12-3-321","volume":"12","author":"CC Blackwell","year":"1979","unstructured":"Blackwell, C. C., Young, H. & Anderson, I. Sensitivity of Neisseria gonorrhoeae to partially purified R-type pyocines and a possible approach to epidemiological typing. J. Med. Microbiol. 12, 321\u2013335 (1979).","journal-title":"J. Med. Microbiol."},{"key":"88_CR101","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1128\/iai.62.6.2379-2386.1994","volume":"62","author":"AA Campagnari","year":"1994","unstructured":"Campagnari, A. A. et al. Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis. Infect. Immun. 62, 2379\u20132386 (1994).","journal-title":"Infect. Immun."},{"key":"88_CR102","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.chom.2024.09.004","volume":"32","author":"E Rotman","year":"2024","unstructured":"Rotman, E. et al. Rapid design of bacteriophage cocktails to suppress the burden and virulence of gut-resident carbapenem-resistant Klebsiella pneumoniae. Cell Host Microbe 32, 1988\u20132003.e1988 (2024).","journal-title":"Cell Host Microbe"},{"key":"88_CR103","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.resmic.2018.05.001","volume":"169","author":"N Hoyle","year":"2018","unstructured":"Hoyle, N. et al. Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report. Res. Microbiol. 169, 540\u2013542 (2018).","journal-title":"Res. Microbiol."}],"container-title":["npj Antimicrobials and Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00088-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00088-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00088-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T20:00:50Z","timestamp":1740772850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44259-025-00088-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88"],"URL":"https:\/\/doi.org\/10.1038\/s44259-025-00088-1","relation":{},"ISSN":["2731-8745"],"issn-type":[{"value":"2731-8745","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}